期刊
CELL
卷 181, 期 1, 页码 24-28出版社
CELL PRESS
DOI: 10.1016/j.cell.2020.03.020
关键词
-
资金
- UK Medical Research Council
- Beckley Foundation
- Alexander Mosley Charitable Trust
After a legally mandated, decades-long global arrest of research on psychedelic drugs, investigation of psychedelics in the context of psychiatric disorders is yielding exciting results. Outcomes of neuroscience and clinical research into 5-Hydroxytryptamine 2A (5-HT2A) receptor agonists, such as psilocybin, show promise for addressing a range of serious disorders, including depression and addiction.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据